JAVIER PADILLA: Open Payments
NPI 1083383186 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 74 payments from 18 companies in 2025. Trend: 2023 $734 · 2024 $1,220 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $299 |
| ABBVIE INC. | 19 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $184 |
| Saluda Medical Americas, Inc. | 4 | $152 |
| GlaxoSmithKline, LLC. | 2 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $90 |
| Lilly USA, LLC | 6 | $81 |
| Novo Nordisk Inc | 3 | $55 |
| Dexcom, Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
Products named: Kerendia, FARXIGA, Evoke, QULIPTA, AREXVY, AIRSUPRA, XIFAXAN, UBRELVY.
Industry payments across AZ — which companies pay providers there.
